MLchartDataset catalogue

Augtyro

Term · Oncology and biomedicine · MLC-T-ONC-000825

A drug used to treat adults with non-small cell lung cancer that has spread and has an abnormal ROS1 gene and adults and children aged 12 years and older with certain types of solid tumors that have an NTRK gene fusion. It is also being studied in the treatment of other types of cancer. Augtyro blocks certain proteins involved in cell signaling and cell growth. Blocking these proteins may help keep cancer cells from growing. Augtyro is a type of kinase inhibitor. Also called repotrectinib.

Table 1. Record
IdentifierMLC-T-ONC-000825
FieldOncology and biomedicine
Synonymsrepotrectinib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000825",
  "term": "Augtyro",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with non-small cell lung cancer that has spread and has an abnormal ROS1 gene and adults and children aged 12 years and older with certain types of solid tumors that have an NTRK gene fusion. It is also being studied in the treatment of other types of cancer. Augtyro blocks certain proteins involved in cell signaling and cell growth. Blocking these proteins may help keep cancer cells from growing. Augtyro is a type of kinase inhibitor. Also called repotrectinib.",
  "synonyms": [
    "repotrectinib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/augtyro/"
}

Record 2,612 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.